Everest Pharmaceuticals Ltd | Excellence in Healthcare

SOFOXEN (Sofosbuvir INN 400 mg)

Therapeutic Class: Hepatology

Pack Size: Each HDPE bottle of SOFOXEN contains 7/28 tablets (each tablet contains Sofosbuvir INN 400 mg), a silica gel desiccant and polyester coil with a child-resistant closure.

View Product Insert

INDICATIONS AND USAGE

Adult Patients
SOFOXEN is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) infection as a component of a combination antiviral treatment regimen.

genotype 1 or 4 infection without cirrhosis or with compensated cirrhosis for use in combination with pegylated interferon and Ribavirin, or with Direct-acting Antivirals (DAAS)
genotype 2 or 3 infection without cirrhosis or with compensated cirrhosis for use in combination with Ribavirin or with Direct-acting Antivirals (DAAs).

Pediatric Patients
SOFOXEN is indicated for the treatment of chronic HCV genotype 2 or 3 infection in pediatric patients 12 years of age and older or weighing at least 35 kg without cirrhosis or with compensated cirrhosis for use in combination with Ribavirin.